Nucleosomal DNA Barcoding for Quantitative Epigenetic Profiling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional ChIP-seq methods face limitations in quantitative comparison across samples due to sensitivity to chromatin input and antibody quality, require large cell numbers, and have low throughput, making it challenging to accurately map histone modifications and epigenetic changes, especially in cancer and low cell number scenarios.

Innovation Solution

The method involves labeling nucleosomal DNA with barcoded adapters that preserve the origin of fragmented DNA, allowing for multiplexed analysis and subsequent mapping of modifications back to their cell of origin, enabling high-throughput, quantitative profiling of nucleosomal DNA states across different cell types and conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional ChIP-seq procedures use separate immunoprecipitations for each sample, then individual sample processing is achieved, but quantitative comparison across samples is compromised due to sensitivity to chromatin input and antibody quality

Engineering Contradiction:
Improvequantitative comparison accuracyVSAvoidseparate immunoprecipitation procedures
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Multiple individual discrete volumes containing different cell populations are combined into a single reaction vessel and processed together through a single immunoprecipitation procedure. Each volume maintains its unique barcode identifier, allowing subsequent computational separation and quantitative comparison of results across different cell types while eliminating variability introduced by separate processing steps

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

A universal immunoprecipitation protocol is developed that can simultaneously process multiple different cell populations in the same reaction. The method uses a common antibody mixture that can immunoprecipitate histone modifications across diverse cell types, making the procedure applicable to broad comparative studies without requiring cell-type-specific optimization

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Quantity of substance

If conventional ChIP-seq experiments are performed on large numbers of cells, then sufficient material for analysis is obtained, but the method cannot be applied to low cell number samples such as rare cell populations or biopsies

Engineering Contradiction:
Improvecell number requirementVSAvoidapplicability to low cell number samples
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The sample population is segmented into multiple individual discrete volumes, each containing a small number of cells or even single cells. By distributing rare cells across many small volumes and processing them collectively, the method preserves the ability to analyze low cell number samples while maintaining sufficient total material for robust statistical analysis

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method transitions from analyzing bulk cell populations to analyzing individual discrete volumes that can be pooled. This dimensional shift allows rare cell populations to be studied by distributing them across many small reaction volumes, then combining results to achieve the statistical power previously requiring large cell numbers

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Productivity

If conventional ChIP-seq processes samples individually, then sample-specific analysis is achieved, but throughput is constrained and processing time increases

Engineering Contradiction:
Improvesample processing throughputVSAvoidprocessing time per sample
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

Multiple samples are merged into a single reaction vessel and processed simultaneously through the entire ChIP-seq workflow. This parallel processing approach increases throughput by eliminating the sequential processing bottleneck, while barcodes enable computational separation of results to maintain sample-specific analysis capabilities

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

Barcodes are incorporated into the adapter sequences before the immunoprecipitation step, enabling subsequent multiplexed processing. This preliminary labeling allows all samples to be prepared for high-throughput sequencing in advance, facilitating batch processing and reducing overall analysis time

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate, high-throughput profiling of nucleosomal DNA modifications, overcoming the limitations of conventional ChIP-seq by allowing quantitative comparison and mapping of modifications with high precision, even in low cell number samples, and providing insights into chromatin landscapes and epigenetic changes.

Implementation Method 1

ligation of an adapter to at least one free end of the fragmented nucleosomal DNA

Methodology Applied
Scientific EffectLigation:

Implementation Method 2

generating RNA copies of the labeled nucleosomal DNA via in vitro transcription from the amplification promoter of the barcoded adapter

Methodology Applied
Scientific EffectIn vitro transcription:

Implementation Method 3

cDNA copies may be generated from the RNA copies using a reverse transcription primer

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 4

The cDNA copies are then amplified using a pair of PCR primers to generate double stranded DNA for sequencing

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS10479986B2Nucleic acid constructs and methods for labeling and detecting nucleosomal DNA modifications
Publication Date: 2019.11.19 THE GENERAL HOSPITAL CORP
  • US10479986B2 patent drawing
  • US10479986B2 patent drawing
  • US10479986B2 patent drawing

AI summary

Embodiments disclosed herein provide methods for identifying cell-type-specific nucleosomal DNA modifications. The methods leverage nucleosomal DNA barcoding and pool-and-split multiplexing to provide high-throughout, quantitative profiling of nucleosomal DNA states. The methods enable the profiling of multiple nucleosomal DNA marks across different cell types and/or conditions thereby linking quantitative changes in chromatin landscapes to different genotypes and chemical and physical perturbations.